Related Experiment Video

Updated: Dec 29, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

685

TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma

Zhou Guoren1, Fan Zhaohui1, Zhu Wei2

  • 1Jiangsu Cancer Hospital, Jiangsu Institute Of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital; 42 Baiziting, Nanjing, Jiangsu, 210009, China (Corresponding Address).

International Journal of Biological Sciences
|February 5, 2020
PubMed

Insights

Inositol 1,4,5-trisphosphate 3-kinase A (ITPKA) is overexpressed in lung adenocarcinoma, promoting cancer growth and metastasis. TFAP2A drives ITPKA expression, suggesting ITPKA as a potential therapeutic target for lung cancer.

Area of Science:

  • Molecular oncology
  • Cellular signaling

Background:

  • Inositol polyphosphates are key regulators of cellular signaling.
  • Aberrant inositol polyphosphate kinase A (ITPKA) expression is linked to cancer aggressiveness.
  • The role of ITPKA in lung adenocarcinoma (LUAD) development is not well understood.

Purpose of the Study:

  • To investigate the role of ITPKA in lung adenocarcinoma (LUAD).
  • To elucidate the mechanism by which ITPKA contributes to LUAD progression.
  • To identify upstream regulators of ITPKA in LUAD.

Main Methods:

  • Analysis of ITPKA expression in LUAD tissues and correlation with clinical parameters.
  • In vitro studies to assess ITPKA's contribution to malignant phenotypes.
  • Investigation of ITPKA's downstream effectors, including epithelial-mesenchymal transition (EMT) and Drebrin 1.
  • Identification of transcription factor TFAP2A as an activator of ITPKA expression.
  • Survival analysis using tissue microarrays (TMA).

Main Results:

  • ITPKA is overexpressed in LUAD and correlates with advanced clinical parameters.
  • ITPKA promotes malignant phenotypes in vitro by inducing EMT and interacting with Drebrin 1.
  • TFAP2A transcriptionally activates ITPKA hyper-expression in LUAD.
  • High ITPKA expression is associated with poor prognosis in LUAD patients.

Conclusions:

  • TFAP2A-induced ITPKA overexpression promotes LUAD progression through EMT and Drebrin 1 interaction.
  • ITPKA is a potential prognostic marker and therapeutic target for LUAD.
Keywords:
Drebrin 1EMTITPKALUADTFAP2A

More Related Videos

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.4K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.6K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K